Multiple drug-resistant bacterial infections have led to an increasing need for an effective disease outbreak response system, such as the One Health platform. While interactions among humans, animals, and ecosystems are crucial and inevitable for survival, the intercommunity transfer of drug resistance genes and the resulting diseases are matters of concern. The concept of bacterial predation and its application in different fields have attracted interest as a natural alternative to traditional antibiotics. Bdellovibrio bacteriovorus, an obligate bacterial predator, preys on a wide range of other bacteria, regardless of their antibiotic resistance status. The present study reviews the potential ability of one of the best studied bacteria among the Bdellovibrio and Like Organisms (BALOs) group B. bacteriovorus, as a One Health solution for pathogen control, delving into its role in interconnected sectors of human, animal, and environmental health, highlighting its prospects as a significant contributor to the One Health approach. Although in vivo animal studies have demonstrated the safety and efficacy of B. bacteriovorus in reducing bacterial burdens in various infection models, clinical trials have not yet been conducted. Understanding the molecular bases of predatory strategies and clinical studies may help in the development of a revolutionary biocontrol agent, such as One Health Solution, for treating infections.